Urban Minority Alcoholism & Drug Abuse Outreach Program (UMADAOP) of Dayton

Located in New York, NY, Urban Minority Alcoholism & Drug Abuse Outreach Program (UMADAOP) of Dayton operates within the NY regulatory framework as a licensed addiction-treatment provider. The facility's programming is outpatient (Outpatient, MAT), not residential. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.

Care levels at Urban Minority Alcoholism & Drug Abuse Outreach Program (UMADAOP) of Dayton

Urban Minority Alcoholism & Drug Abuse Outreach Program (UMADAOP) of Dayton is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Urban Minority Alcoholism & Drug Abuse Outreach Program (UMADAOP) of Dayton provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.

Insurance and payment

Urban Minority Alcoholism & Drug Abuse Outreach Program (UMADAOP) of Dayton accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Before you call

Pre-admission documentation for Urban Minority Alcoholism & Drug Abuse Outreach Program (UMADAOP) of Dayton should include ASAM-framework level-of-care justification, plan-specific Verification of Benefits with network-contract confirmation, written MAT policy for opioid use disorder patients where applicable, and licensure/accreditation verification. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.